Downloadable Slides

Share

Program Content

Activities

  • ET in ER+/HER2- Breast Cancer
    Navigating Endocrine Therapy and Resistance in ER+/HER2- Breast Cancer
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 01, 2023

  • SERDs and Novel ET in ER+/HER2- Breast Cancer
    Oral SERDs and Novel Endocrine Therapies: Reshaping the Treatment Landscape for ER+/HER2- Breast Cancer
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 01, 2023

Provided by

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca